Search Results for: BioNTech

Is the end of the COVID-19 pandemic possible in five months’ time?

Is the end of the COVID-19 pandemic possible in five months’ time?

According to the announcement, by the end of August, every willing Polish citizen is to receive the vaccination for COVID-19. In the second half of April, the vaccine for COVID-19 of the fourth company – Johnson & Johnson (J&J) – will come to Poland. This is to greatly facilitate the implementation of the National Vaccination…

Poland to resell vaccines against COVID-19
|

Poland to resell vaccines against COVID-19

Deputy Health Minister Maciej Miłkowski said that Poland will resell 4 million of the 20 million vaccines purchased from AstraZeneca. The vaccines are to be resold to countries outside the European Union (EU).   Poland buys 20 million doses of AstraZeneca vaccines Deputy Health Minister Maciej Miłkowski announced that Poland will resell 4 million of…

FDA: Pfizer is authorised to distribute the vaccine for COVID-19

FDA: Pfizer is authorised to distribute the vaccine for COVID-19

The SARS-CoV-2 coronavirus continues to spread around the world. However, there is one good message. Indeed, on Friday, the first company obtained official marketing authorisation for the COVID-19 vaccine in the United States. This is about Pfizer and BioNTech preparation. FDA authorises the marketing of the first vaccine for COVID-19 “On 11 December 2020, the…

Vaccinations on COVID-19 in the first quarter of 2021

Vaccinations on COVID-19 in the first quarter of 2021

Yesterday, the Government announced a draft National Vaccination Program against COVID-19. Under the prepared assumptions, vaccinations are to be voluntary, but the vaccinated are to have certain privileges. Recruitment of the facilities that will carry out the vaccinations continues Last Friday, the NFZ announced the recruitment of institutions to the National Sars-CoV-2 Vaccination Program. Until…

Moderna: COVID-19 vaccine effective at 94.5%

Moderna: COVID-19 vaccine effective at 94.5%

Another company has announced success in clinical trials. This is about a product developed by Moderna. The vaccine in the third phase of clinical trials showed 94.5% effectiveness. The company wants to apply for an accelerated market authorisation. Scientific battle for victory with COVID-19 The race for the groundbreaking discovery of an effective preparation for…

Biomed Lublin: drug for COVID-19 goes into ampoules

Biomed Lublin: drug for COVID-19 goes into ampoules

Biomed Lublin has completed the process of isolating immunoglobulin against Sars-CoV-2 from the recovered plasma. Today, the company will carry out the process of aseptic filling of the preparation into ampoules. Does this mean that Poland already has a drug for COVID-19? Drug has to undergo many tests… Biomed Lublin is working hard on the…

Phil Krzyzek new CEO of Merck

Phil Krzyzek new CEO of Merck

On 1 September 2020, Phil Krzyzek took over as General Manager Biopharma Poland and Managing Director Merck Sp. z o.o science and technology company. The graduate of microbiology and microbiological technology has been associated with the pharmaceutical industry for years. He has been working within the structures of Merck for nearly four years. Since the…

Coronavirus vaccine: another successful study

Coronavirus vaccine: another successful study

Are we approaching a breakthrough in the development of a vaccine for the coronavirus causing COVID-19 disease? Another company informed about the results of the first phase of clinical trials. The vaccine developed by the biotechnological company Moderna Therapeutics is causing an immunological response. However, it will be subjected to further testing. COVID-19 vaccine –…